×
Best Practices has moved to a work-at-home response to support the safety of our employees, clients and home communities. We are serving all clients and partners through our Video Meetings TelePlatform as well as through our existing research, support and communication channels. Please reach out as you have business needs or require insight to inform your operations and decisions in this unusual time through which we are all navigating. We are cheering for your safety and wellbeing. We are here to support you.

A rapidly changing marketplace, coupled with a restricted promotional environment have pushed the Medical Affairs (MA) function beyond its traditional support role into a more prominent oncology launch role that extends from the pre-launch phase to well beyond market entry.

From identification and engagement of key thought leaders to guidance of commercial strategies and launch resources management, the Medical Affairs function plays a vital role in a host of oncology launch activities.

Best Practices, LLC undertook this study to help companies focused on oncology therapies find better ways to develop successful launch strategies. This research delivers current data, insights and best practices in oncology launch excellence from Medical Affairs leaders at top biopharmaceutical companies.

§ Medical Affairs leads TL Activities and plays a key role between companies and decision makers during launch process. This requires companies to create strong MSL teams, acquire the right talent and provide effective training.

§ Medical Affairs also plays a critical role in internal education and guiding commercial strategies regarding products. This provides Medical Affairs leaders with the opportunity to convey the needs of key decision makers, thus companies to improve their products.